arginine has been researched along with Cancer, Second Primary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (73.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baralle, D; Bonthron, DT; Charlton, R; Cole, TR; De Vos, M; Glaser, AW; Hayward, BE; Maher, ER; Mann, JR; McKeown, CM; Picton, S; Rankin, J; Sheridan, E; Taylor, GR; Yates, JR | 1 |
| Ma, X; Ren, C; Sheng, Z; Wang, B; Xia, B; Zhang, W | 1 |
| Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF | 1 |
| Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
| Castel, V; Esquembre, C; Ferrís, J; Lopez-Andrew, JA; Senent, ML; Verdeguer, A | 1 |
| Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
| Evans, WE; McLeod, HL | 1 |
| Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE | 1 |
| Muse, IM; Wiernik, PH | 1 |
| Broeker, PL; Pomykala, H; Rowley, JD; Super, HG; Tanabe, S; Thirman, MJ; Yonebayashi, Y; Zeleznik-Le, N | 1 |
| Benaim, E; Crist, WM; Hudson, MM; Liu, Q; Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
| Bosq, J; Carde, P; Cosset, JM; Decaudin, D; Dhermain, F; Girinsky, T; Hayat, M; Juliéron, M; Koscielny, S; Munck, JN | 1 |
| Felix, CA; Lange, BJ; Megonigal, MD; Nowell, PC; Pegram, LD; Rappaport, EF; Rowley, JD | 1 |
| Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Prieto, F; Ruiz, JG; Tasso, MJ; Verdeguer, A | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
5 review(s) available for arginine and Cancer, Second Primary
| Article | Year |
|---|---|
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2013 |
Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.
Topics: Bone Neoplasms; Child; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Pelvic Bones; Sarcoma, Ewing; Teniposide | 1994 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Clinical pharmacokinetics and pharmacodynamics of epipodophyllotoxins.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Etoposide; Humans; Leukemia; Neoplasms; Neoplasms, Second Primary; Teniposide; Topoisomerase II Inhibitors | 1993 |
Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Glioblastoma; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Male; Neoplasms, Second Primary; Neurofibromatosis 1; Teniposide | 1996 |
2 trial(s) available for arginine and Cancer, Second Primary
| Article | Year |
|---|---|
Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Patient Compliance; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Radiotherapy; Teniposide; Time Factors | 1996 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
8 other study(ies) available for arginine and Cancer, Second Primary
| Article | Year |
|---|---|
PMS2 mutations in childhood cancer.
Topics: Adenosine Triphosphatases; Adolescent; Arginine; Astrocytoma; Cafe-au-Lait Spots; Child; Colonic Polyps; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Founder Effect; Genetic Predisposition to Disease; Glioma; Humans; Leukemia, T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Mismatch Repair Endonuclease PMS2; Mutation; Neoplasms; Neoplasms, Second Primary; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United Kingdom | 2006 |
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine | 2004 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Control Studies; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Risk Factors; Teniposide | 1994 |
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Base Sequence; Binding Sites; Centromere; Child; Child, Preschool; Chromatin; Chromosomes, Human, Pair 11; Consensus Sequence; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Male; Middle Aged; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Telomere; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Tumor Cells, Cultured | 1996 |
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Female; Growth Disorders; Humans; Hydrocortisone; Leukemic Infiltration; Life Tables; Male; Meninges; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Teniposide; Testis; Time Factors; Treatment Outcome; Vincristine | 1996 |
t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 3; Combined Modality Therapy; Cyclophosphamide; DNA, Complementary; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Radiation-Induced; Male; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Teniposide; Translocation, Genetic; Transplantation Conditioning; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 2000 |
Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
Topics: Child, Preschool; Female; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |